알부민에 의한 아나필락시스를 보인 소아에서 성공적인 탈감작 적용 1예 = Successful desensitization of a patient with albumin hypersensitivity

다국어 초록 (Multilingual Abstract)

There have been few cases of albumin hypersensitivity reported, and there is limited information on this condition. When a patient is anaphylactic to a certain drug and no alternative drug is available to treat the underlying condition, desensitization is a reasonable option and can be performed successfully to treat the patient. A standard 12-step, 3-solution rapid desensitization protocol allows the safe readministration of a medication after certain types of immediate hypersensitivity. However, we demonstrated that a new 10-step, 1-solution desensitization protocol using antihistamine and leukotriene receptor antagonist as premedications, which was effective and safe in a patient with hypersensitivity. We report a 13-year-old boy with Gorham-stout syndrome who was presented with newly acquired albumin anaphylaxis and successfully treated with the 10-step rapid drug desensitization protocol. (Allergy Asthma Respir Dis 2017:5:117-120)

참고문헌 (Reference)

1 Dellinger MT, "Viewpoints on vessels and vanishing bones in Gorham-Stout disease" 63 : 47-52, 2014

2 Uppsala Monitoring Centre, "The use of the WHO-UMC system for standardised case causality assessment" Uppsala Monitoring Centre

3 Ataca P, "Successful desensitization of a patient with rituximab hypersensitivity" 2015 : 524507-, 2015

4 Li Q, "Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin" 135 : 90-94, 2014

5 Hendrickson JE, "Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication" 56 : 2587-2596, 2016

6 윤주영, "Gorham 병으로 진단된 9세 남아에서 파미드로네이트 치료 경험 1례" 대한소아내분비학회 16 (16): 189-192, 2011

7 Liu A, "Desensitization regimens for drug allergy: state of the art in the 21st century" 41 : 1679-1689, 2011

8 Wazny LD, "Desensitization protocols for vancomycin hypersensitivity" 35 : 1458-1464, 2001

9 U.S.Department of Health and Human Services, "Common terminology criteria for adverse events (CTCAE) Ver. 4.0" National Cancer Institute

10 Thong BY, "Clinical applications of drug desensitization in the Asia-Pacific region" 1 : 2-11, 2011

11 원하경, "Cetuximab에 의한 아나필락시스를 보인 환자에서 성공적인 탈감작 적용 1예" 대한 소아알레르기 호흡기학회 3 (3): 294-296, 2015

12 Abdel-Aziz S, "Anaphylactoid shock with infusion of 5% albumin in a patient under general anesthesia" 2 : 214-216, 2012

13 Fujita A, "Anaphylactoid shock in a patient following 5% human serum albumin infusion during off-pump coronary artery bypass grafting" 21 : 396-398, 2007

14 Gilstad CW, "Anaphylactic transfusion reactions" 10 : 419-423, 2003

15 Gruchalla RS, "Acute drug desensitization" 28 (28): 63-64, 1998